Grant: Doctoral Research Award - PA: Digestive Health (SHOPP)
University of Guelph
$11,000.00
Virulence determinants of Fusobacterium nucleatum and relevance to Inflammatory Bowel Disease
EF 2009-10
Résumé
Inflammatory Bowel Disease (IBD) is an umbrella term used to describe a group of chronic, relapsing/remitting disorders of the gastrointestinal tract (GIT). Canada has among the highest incidences of IBD in the world affecting 200,000 Canadians. While the precise aetiology of IBD is unknown, dysbiosis, an imbalance between beneficial and harmful bacterial species in the gut, is a leading hypothesis for the role of bacteria in IBD. Disruption of the intestinal epithelial barrier in IBD enables these harmful species to stimulate the mucosal immune system, resulting in the initiation and perpetuation of intestinal inflammation. Thus, the search for potentially pathogenic microbial residents of the GI tract is a current research focus
Fusobacterium nucleatum is a member of the human microflora, including the GIT. F.nucleatum is a known pathogen and has a well-characterized role in periodontitis in the oral setting. I have determined that F.nucleatum can be frequently isolated from intestinal biopsy specimens, and furthermore there is a correlation between recovery of F.nucleatum and the IBD status of the host. I have found that F.nucleatum intestinal isolates are able to invade intestinal epithelial cells in vitro, and that strains from IBD patients tend to be more invasive than strains from healthy controls. Additionally, these strains vary in their abilities to elicit a pro-inflammatory response from host cells, suggesting that some isolates are more virulent than others. A difference in virulence in F.nucleatum strains has similarly been noted in the oral niche. As yet, the reason why some isolates behave pathogenically whilst others do not is unknown. I propose that some F.nucleatum strains possess genes that contribute to the aetiology of IBD through promotion of internalization of the bacteria into cells of the intestinal mucosa. My goal is to identify these genes by comparing the whole genome sequences of F.nucleatum isolates from IBD patients and heal
Programme
Doctoral Research Award - PA: Digestive Health (SHOPP)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
195876
Name
Strauss Jaclyn C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Digestive Health Foundation
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Virulence determinants of Fusobacterium nucleatum and relevance to Inflammatory Bowel Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$11,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA: Digestive Health (SHOPP)
Keyworddelim
Anaerobic Bacteriology; Biochemical Immunology; Bioinformatics; Gene Sequence Alignment; Immuofluorescence Microscopy; Microbial Genetics; Molecular Biology; Mutagenesis; Real-Time Pcr; Tissue Culture
Abstract
Inflammatory Bowel Disease (IBD) is an umbrella term used to describe a group of chronic, relapsing/remitting disorders of the gastrointestinal tract (GIT). Canada has among the highest incidences of IBD in the world affecting 200,000 Canadians. While the precise aetiology of IBD is unknown, dysbiosis, an imbalance between beneficial and harmful bacterial species in the gut, is a leading hypothesis for the role of bacteria in IBD. Disruption of the intestinal epithelial barrier in IBD enables these harmful species to stimulate the mucosal immune system, resulting in the initiation and perpetuation of intestinal inflammation. Thus, the search for potentially pathogenic microbial residents of the GI tract is a current research focus
Fusobacterium nucleatum is a member of the human microflora, including the GIT. F.nucleatum is a known pathogen and has a well-characterized role in periodontitis in the oral setting. I have determined that F.nucleatum can be frequently isolated from intestinal biopsy specimens, and furthermore there is a correlation between recovery of F.nucleatum and the IBD status of the host. I have found that F.nucleatum intestinal isolates are able to invade intestinal epithelial cells in vitro, and that strains from IBD patients tend to be more invasive than strains from healthy controls. Additionally, these strains vary in their abilities to elicit a pro-inflammatory response from host cells, suggesting that some isolates are more virulent than others. A difference in virulence in F.nucleatum strains has similarly been noted in the oral niche. As yet, the reason why some isolates behave pathogenically whilst others do not is unknown. I propose that some F.nucleatum strains possess genes that contribute to the aetiology of IBD through promotion of internalization of the bacteria into cells of the intestinal mucosa. My goal is to identify these genes by comparing the whole genome sequences of F.nucleatum isolates from IBD patients and heal
Competitiondate
200910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Strauss, Jaclyn C
Approvedterm
1 an 0 mois
Cihrcontribution2
SPIR~ $11,000~ $0~